跳至主要内容
临床试验/NCT04393779
NCT04393779终止不适用

Beating Heart Mitral Valve REPair With the HARPOON™ System: ReaL World Outcomes From a multICenter observATional European Registry

Edwards Lifesciences14 个研究点 分布在 3 个国家目标入组 26 人开始时间: 2020年10月2日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
26
试验地点
14
主要终点
Freedom From Re-operation Due to Recurrent Severe Mitral Regurgitation Through 1-year Post-implant

研究概览

简要总结

To collect data on the HARPOON™ Mitral Valve Repair System for use in patients with severe degenerative mitral regurgitation due to posterior leaflet prolapse.

详细描述

This is a single arm, prospective, multicenter, post-market, observational registry that will evaluate subjects for up to 5 years post treatment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects who are clinically suitable for treatment with the HARPOON™ System, as per the Instructions for Use (IFU), will be evaluated for inclusion in the registry.

排除标准

  • 未提供

结局指标

主要结局

Freedom From Re-operation Due to Recurrent Severe Mitral Regurgitation Through 1-year Post-implant

时间窗: 1 year post-implant

Subject's freedom from re-operation due to recurrent severe mitral regurgitation through 1-year post-implant

次要结局

未报告次要终点

研究者

发起方
Edwards Lifesciences
申办方类型
Industry
责任方
Sponsor

研究点 (14)

Loading locations...

相似试验

Observational Registry on the HARPOON Device | 临床试验